Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Moderna says CDC panel recommends its COVID-19 vaccine for adults

Published 12/19/2020, 10:42 PM
Updated 12/19/2020, 10:55 PM
© Reuters. FILE PHOTO: Vials and medical syringe are seen in front of Moderna logo in this illustration

(Reuters) - Moderna (NASDAQ:MRNA) Inc said on Saturday the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.

The panel voted 11-0 in favor of the vaccine, the company said in a press release.

The vote result came a day after the Food and Drug Administration's authorization for emergency use of Moderna's COVID-19 vaccine.

"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.

Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc (NYSE:PFE) and German partner BioNTech SE (NASDAQ:BNTX) got the green light for emergency use.

U.S. distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.

Latest comments

godd news to vaccine, now as usual the stock going down for mrna. if the vaccine cause reaction and destroy all the body, stock will going up
Oil price up to $51 or more this week
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.